Rare diseases
Investigational molecules
Locations
Ul. Mariana Smoluchowskiego 17, 80-214 Gdansk, Poland
Uniwersyteckie Centrum Kliniczne in Gdansk, Poland specialises in clinical trials of conditions such as Non-small cell lung cancer, Plasma cell myeloma, Neoplasm, Acute myeloid leukaemia, and other specialisations. This site conducts important research.
At Uniwersyteckie Centrum Kliniczne in Gdansk, research in immune system diseases focuses on conditions such as myasthenia gravis and the prevention of Herpes Zoster in immunocompromised children and adolescents. These studies are designed to better understand treatment response, immune protection, and overall safety in younger patients.
This area of research supports improved care for children with complex immune-related conditions, with a strong emphasis on therapy effectiveness and protection against infection.
Clinical trials in nervous system diseases at this site examine relapsing-remitting multiple sclerosis and spinal muscular atrophy, with the goal of improving treatment outcomes for pediatric patients. The work includes efforts to evaluate how well therapies are tolerated and how they affect disease control and functional development.
The research reflects a broad commitment to advancing care in pediatric neurology, especially for conditions that can significantly affect movement, strength, and long-term neurological health.
Studies in musculoskeletal diseases at Uniwersyteckie Centrum Kliniczne are closely linked to disorders that affect muscle function and physical ability, particularly spinal muscular atrophy and myasthenia gravis. These trials aim to determine whether emerging therapies can improve strength, mobility, and everyday functioning in young patients.
This research area helps clarify how new approaches may support better physical outcomes and quality of life for children living with neuromuscular conditions.
Clinical trials currently enrolling participants at this site.
Safety and Tolerability of Benralizumab in Patients with HES, EGPA, or Asthma Who Completed a Prior Study
PolandLong-term Safety and Efficacy of Remibrutinib in Adults with Moderate to Severe Hidradenitis Suppurativa
PolandStudy of BNT327 and a drug combination for patients with untreated metastatic or locally recurrent triple-negative breast cancer
PolandStudy of BNT327 with etoposide and carboplatin compared to atezolizumab with etoposide and carboplatin for patients with untreated extensive-stage small-cell lung cancer
PolandStudy of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
PolandStudy of RVU120 treatment in patients with myelodysplastic syndrome, solid tumors, or acute myeloid leukemia who benefited from previous RVU120 therapy
PolandLong-term safety study of oral povorcitinib in patients with hidradenitis suppurativa, prurigo nodularis, or vitiligo who previously participated in clinical trials
PolandStudy of personalized treatment using drug combination therapy for young women with early stage hormone receptor-positive breast cancer based on gene expression testing
PolandStudy of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it
PolandStudy of Lutetium-177-DOTA-TATE with octreotide LAR in newly diagnosed patients with advanced gastroenteropancreatic neuroendocrine tumors (GEP-NET) with high disease burden
PolandStudy on the Safety and Effectiveness of BNT327 with Chemotherapy for Patients with Non-Small Cell Lung Cancer
PolandPolandMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
